Gridelli, C <br/><br/>
Single agent docetaxel plus granulocyte-colony stimulating factor (G-CSF) in previously treated patients with advanced non small cell lung cancer. A phase II study and review of the literature.  [electronic resource] 

 -  Anticancer research   
 - 1077-84 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Review 
<br/><br/><label>ISSN: </label>0250-7005 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents, Phytogenic--adverse effects<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Deoxycytidine--analogs & derivatives<br/>Docetaxel<br/>Drug Administration Schedule<br/>Female<br/>Granulocyte Colony-Stimulating Factor--adverse effects<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Paclitaxel--adverse effects<br/>Survival Analysis<br/>Taxoids<br/>Gemcitabine